Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Live Attenuated Vaccines market report explains the definition, types, applications, major countries, and major players of the Live Attenuated Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GlaxoSmithKline
Astellas Pharma
Merck
Serum Institute Of India
Sanofi
Johnson & Johnson
Pfizer
CSL
By Type:
Bacterial
Viral
By End-User:
Hospitals
Clinics
Research Institutes
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Live Attenuated Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Live Attenuated Vaccines Outlook to 2028- Original Forecasts
-
2.2 Live Attenuated Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Live Attenuated Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Live Attenuated Vaccines Market- Recent Developments
-
6.1 Live Attenuated Vaccines Market News and Developments
-
6.2 Live Attenuated Vaccines Market Deals Landscape
7 Live Attenuated Vaccines Raw Materials and Cost Structure Analysis
-
7.1 Live Attenuated Vaccines Key Raw Materials
-
7.2 Live Attenuated Vaccines Price Trend of Key Raw Materials
-
7.3 Live Attenuated Vaccines Key Suppliers of Raw Materials
-
7.4 Live Attenuated Vaccines Market Concentration Rate of Raw Materials
-
7.5 Live Attenuated Vaccines Cost Structure Analysis
-
7.5.1 Live Attenuated Vaccines Raw Materials Analysis
-
7.5.2 Live Attenuated Vaccines Labor Cost Analysis
-
7.5.3 Live Attenuated Vaccines Manufacturing Expenses Analysis
8 Global Live Attenuated Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Live Attenuated Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Live Attenuated Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global Live Attenuated Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Live Attenuated Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bacterial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Viral Consumption and Growth Rate (2017-2022)
-
9.2 Global Live Attenuated Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Live Attenuated Vaccines Market Analysis and Outlook till 2022
-
10.1 Global Live Attenuated Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Live Attenuated Vaccines Consumption (2017-2022)
-
10.2.2 Canada Live Attenuated Vaccines Consumption (2017-2022)
-
10.2.3 Mexico Live Attenuated Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.2 UK Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.3 Spain Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.4 Belgium Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.5 France Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.6 Italy Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.7 Denmark Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.8 Finland Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.9 Norway Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.10 Sweden Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.11 Poland Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.12 Russia Live Attenuated Vaccines Consumption (2017-2022)
-
10.3.13 Turkey Live Attenuated Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.2 Japan Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.3 India Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.4 South Korea Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.8 Thailand Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.9 Singapore Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.11 Philippines Live Attenuated Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam Live Attenuated Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.2 Colombia Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.3 Chile Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.4 Argentina Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.6 Peru Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico Live Attenuated Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador Live Attenuated Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Live Attenuated Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait Live Attenuated Vaccines Consumption (2017-2022)
-
10.6.3 Oman Live Attenuated Vaccines Consumption (2017-2022)
-
10.6.4 Qatar Live Attenuated Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Live Attenuated Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Live Attenuated Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Live Attenuated Vaccines Consumption (2017-2022)
-
10.7.2 South Africa Live Attenuated Vaccines Consumption (2017-2022)
-
10.7.3 Egypt Live Attenuated Vaccines Consumption (2017-2022)
-
10.7.4 Algeria Live Attenuated Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Live Attenuated Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand Live Attenuated Vaccines Consumption (2017-2022)
11 Global Live Attenuated Vaccines Competitive Analysis
-
11.1 GlaxoSmithKline
-
11.1.1 GlaxoSmithKline Company Details
-
11.1.2 GlaxoSmithKline Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GlaxoSmithKline Live Attenuated Vaccines Main Business and Markets Served
-
11.1.4 GlaxoSmithKline Live Attenuated Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Astellas Pharma
-
11.2.1 Astellas Pharma Company Details
-
11.2.2 Astellas Pharma Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Astellas Pharma Live Attenuated Vaccines Main Business and Markets Served
-
11.2.4 Astellas Pharma Live Attenuated Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merck
-
11.3.1 Merck Company Details
-
11.3.2 Merck Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merck Live Attenuated Vaccines Main Business and Markets Served
-
11.3.4 Merck Live Attenuated Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Serum Institute Of India
-
11.4.1 Serum Institute Of India Company Details
-
11.4.2 Serum Institute Of India Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Serum Institute Of India Live Attenuated Vaccines Main Business and Markets Served
-
11.4.4 Serum Institute Of India Live Attenuated Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Sanofi
-
11.5.1 Sanofi Company Details
-
11.5.2 Sanofi Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Sanofi Live Attenuated Vaccines Main Business and Markets Served
-
11.5.4 Sanofi Live Attenuated Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Johnson & Johnson
-
11.6.1 Johnson & Johnson Company Details
-
11.6.2 Johnson & Johnson Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Johnson & Johnson Live Attenuated Vaccines Main Business and Markets Served
-
11.6.4 Johnson & Johnson Live Attenuated Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Pfizer
-
11.7.1 Pfizer Company Details
-
11.7.2 Pfizer Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Pfizer Live Attenuated Vaccines Main Business and Markets Served
-
11.7.4 Pfizer Live Attenuated Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 CSL
-
11.8.1 CSL Company Details
-
11.8.2 CSL Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 CSL Live Attenuated Vaccines Main Business and Markets Served
-
11.8.4 CSL Live Attenuated Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
12 Global Live Attenuated Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global Live Attenuated Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Bacterial Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Viral Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Live Attenuated Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Live Attenuated Vaccines Market Analysis and Outlook to 2028
-
13.1 Global Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Live Attenuated Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Live Attenuated Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Live Attenuated Vaccines
-
Figure of Live Attenuated Vaccines Picture
-
Table Global Live Attenuated Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Live Attenuated Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Bacterial Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Table North America Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure United States Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure Germany Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure China Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure Brazil Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania Live Attenuated Vaccines Consumption by Country (2017-2022)
-
Figure Australia Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Live Attenuated Vaccines Main Business and Markets Served
-
Table GlaxoSmithKline Live Attenuated Vaccines Product Portfolio
-
Table Astellas Pharma Company Details
-
Table Astellas Pharma Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Live Attenuated Vaccines Main Business and Markets Served
-
Table Astellas Pharma Live Attenuated Vaccines Product Portfolio
-
Table Merck Company Details
-
Table Merck Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Live Attenuated Vaccines Main Business and Markets Served
-
Table Merck Live Attenuated Vaccines Product Portfolio
-
Table Serum Institute Of India Company Details
-
Table Serum Institute Of India Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute Of India Live Attenuated Vaccines Main Business and Markets Served
-
Table Serum Institute Of India Live Attenuated Vaccines Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Live Attenuated Vaccines Main Business and Markets Served
-
Table Sanofi Live Attenuated Vaccines Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Live Attenuated Vaccines Main Business and Markets Served
-
Table Johnson & Johnson Live Attenuated Vaccines Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Live Attenuated Vaccines Main Business and Markets Served
-
Table Pfizer Live Attenuated Vaccines Product Portfolio
-
Table CSL Company Details
-
Table CSL Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Live Attenuated Vaccines Main Business and Markets Served
-
Table CSL Live Attenuated Vaccines Product Portfolio
-
Figure Global Bacterial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Viral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
